The ability of gram-negative bacterial infections to promote NSCLC progression by a Toll-like receptor 4 (TLR4)/myeloid differentiation primary response 88 (MyD88) and IL-33 pathway may be related to increased glycolysis by the induction of GLUT1 [17]. This evidence concerns the gene IL33 and non-small cell lung carcinoma.